DDB Board Regulation No. 3, s. 2020 placed CBD products containing no more than 0.1% THC in Schedule 4 of the Philippine drug schedule. The board said medical marijuana remained illegal and that access still required a specialist prescription and an FDA compassionate permit; the regulation did not create a consumer-CBD market.[1][2]
Listed for context. No score change is recorded for Philippines here.
References
- Philippines Dangerous Drugs Board — Board Regulation No. 3, s. 2020CBD products with no more than 0.1% THC in Schedule 4.
- GMA News — Medical marijuana still illegal, only compassionate use allowed, DDB says (17 February 2020)DDB statement on limited compassionate use.
Checked. The date and the event were compared with a source that was read.